Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01457014 · ClinicalTrials.gov registry record · NA

Sleep Disordered Breathing and Chronic Pain

A NA study, sponsored by Philips Respironics.

Completed
Registry status
NA
Development phase
88
Enrollment target

NCT01457014: Completed NA study, sponsored by Philips Respironics.

NCT01457014 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01457014, a NA study, has completed, sponsored by Philips Respironics.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate positive pressure in patients with chronic pain taking opioid medications who have sleep disordered breathing.

Primary Outcome

The number of Apnea-Hypopnea Events, Central Apneas, Obstructive Apneas and Hypopneas were compared among no treatment, CPAP, Auto SV and Manual SV.

Interventions

  • DEVICE Continuous positive airway pressure
  • DEVICE servo ventilation auto
  • DEVICE servo ventilation manual

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2011-09
Est. Completion 2013-09
Phase NA
Philips Respironics

35 total trials

What the finished NCT01457014 record still lists

NCT01457014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 3 interventions - of which Continuous positive airway pressure is the first listed.

NCT01457014 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01457014 about?

NCT01457014 is a clinical study titled "Sleep Disordered Breathing and Chronic Pain". The purpose of this study is to evaluate positive pressure in patients with chronic pain taking opioid medications who have sleep disordered breathing.

What is the current status of trial NCT01457014?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2011-09. Estimated completion is 2013-09.

What interventions are being tested in trial NCT01457014?

The interventions under investigation include: Continuous positive airway pressure (DEVICE), servo ventilation auto (DEVICE), servo ventilation manual (DEVICE).

Who is sponsoring clinical trial NCT01457014?

This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01457014's enrollment target sits among peer trials

88 972nd of 2000 higher than 1,027 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01457014, the US trial registry maintained by the National Library of Medicine. NCT01457014 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.